National Academies Press: OpenBook
« Previous: 8 Concluding Remarks
Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×

References

Bickford, L. R., G. Agollah, R. Drezek, and T. K. Yu. 2010. Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy. Breast Cancer Research and Treatment 120(3):547–555.

Boisselier, E., and D. Astruc. 2009. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chemical Society Reviews 38(6):1759–1782.

Davis, M. E., J. E. Zuckerman, C. H. Choi, D. Seligson, A. Tolcher, C. A. Alabi, Y. Yen, J. D. Heidel, and A. Ribas. 2010. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291):1067–1070.

Debbage, P. 2009. Targeted drugs and nanomedicine: Present and future. Current Pharmaceutical Design 15(2):153–172.

Fan, R., O. Vermesh, A. Srivastava, B. K. H. Yen, L. Qin, N. Ahmad, G. A. Kwong, C. Liu, J. Gould, L. Hood, and J. R. Heath. 2008. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nature Biotechnology 26(12):1373–1378.

FDA (Food and Drug Administration). 2009. FDA regulation of nanotechnology products. http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/NanotechnologyTaskForce/ucm115441.htm (accessed April 29, 2011).

Fischer, H. C., and W. C. W. Chan. 2007. Nanotoxicity: The growing need for in vivo study. Current Opinion in Biotechnology 18(6):565–571.

Gao, J. H., H. W. Gu, and B. Xu. 2009. Multifunctional magnetic nanoparticles: Design, synthesis and biomedical applications. Accounts of Chemical Research 42(8):1097–1107.

Heath, J. R., M. E. Davis, and L. Hood. 2009. Nanomedicine targets cancer. Scientific American 300(2):44–51.

IOM (Institute of Medicine). 2010. Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington, DC: The National Academies Press.

Keiner, S. 2008. Room at the bottom? Potential state and local strategies for managing the risks and benefits of nanotechnology. http://www.nanotechproject.org/process/assets/files/6112/pen11_keiner.pdf (accessed April 29, 2011).

Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×

Kostarelos, K., A. Bianco, and M. Prato. 2009. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nature Nanotechnology 4(10):627–633.

Lammers, T., W. E. Hennink, and G. Storm. 2008. Tumour-targeted nanomedicines: Principles and practice. British Journal of Cancer 99(3):392–397.

Li, K. 2010. Biologic barriers to in vivo nanomedicine delivery: Major hurdles for clinical translation. Paper presented at the NCPF workshop on Policy Issues in Nanotechnology and Oncology, Washington, DC.

McLaren, C. E., S. Fujikawa-Brooks, W. P. Chen, D. L. Gillen, D. Pelot, E. W. Gerner, and F. L. Meyskens Jr. 2008. Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas. Cancer Prevention Research 1(7):514–521.

Meyskens, J., F. L., C. E. McLaren, D. Pelot, S. Fujikawa-Brooks, P. M. Carpenter, E. Hawk, G. Kelloff, M. J. Lawson, J. Kidao, J. McCracken, C. G. Albers, D. J. Ahnen, D. K. Turgeon, S. Goldschmid, P. Lance, C. H. Hagedorn, D. L. Gillen, and E. W. Gerner. 2008. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial. Cancer Prevention Research 1(1):32–38.

Moghimi, S. M., A. C. Hunter, and J. C. Murray. 2005. Nanomedicine: Current status and future prospects. FASEB Journal 19(3):311–330.

NCI (National Cancer Institute). 2010a. NCI Alliance for Nanotechnology in Cancer. http://nano.cancer.gov/ (accessed November 17, 2010).

NCI. 2010b. Understanding nanotechnology. http://nano.cancer.gov/learn/understanding/ (accessed January 20, 2011).

Nie, S. M., Y. Xing, G. J. Kim, and J. W. Simons. 2007. Nanotechnology applications in cancer. Annual Review of Biomedical Engineering 9:257–288.

NNI (National Nanotechnology Initiative). 2010. What is nanotechnology? http://www.nano.gov/html/facts/whatIsNano.html (accessed January 3, 2011).

Peer, D., J. M. Karp, S. Hong, O. C. FaroKhzad, R. Margalit, and R. Langer. 2007. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology 2(12):751–760.

Riehemann, K., S. W. Schneider, T. A. Luger, B. Godin, M. Ferrari, and H. Fuchs. 2009. Nanomedicine—Challenge and perspectives. Angewandte Chemie International Edition in English 48(5):872–897.

Sakamoto, J. H., A. L. van de Ven, B. Godin, E. Blanco, R. E. Serda, A. Grattoni, A. Ziemys, A. Bouamrani, T. Hu, S. I. Ranganathan, E. De Rosa, J. O. Martinez, C. A. Smid, R. M. Buchanan, S. Y. Lee, S. Srinivasan, M. Landry, A. Meyn, E. Tasciotti, X. Liu, P. Decuzzi, and M. Ferrari. 2010. Enabling individualized therapy through nanotechnology. Pharmacology Research 62(2):57–89.

Schierow, L.-J. 2008. Engineered nanoscale materials and derivative products: Regulatory challenges, Order Code RL34332 Congressional Research Service.

Siddiqui, I. A., V. M. Adhami, D. J. Bharali, B. B. Hafeez, M. Asim, S. I. Khwaja, N. Ahmad, H. Cui, S. A. Mousa, and H. Mukhtar. 2009. Introducing nanochemoprevention as a novel approach for cancer control: Proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Research 69(5):1712–1716.

Siegrist, M., M. E. Cousin, H. Kastenholz, and A. Wiek. 2007. Public acceptance of nanotechnology foods and food packaging: The influence of affect and trust. Appetite 49(2):459–466.

Song, Y., X. Li, and X. Du. 2009. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. European Respiratory Journal 34(3):559–567.

Suresh, S. 2007. Biomechanics and biophysics of cancer cells. Acta Biomateriala 3(4):413–438. Trehin, R., J. L. Figueiredo, M. J. Pittet, R. Weissleder, L. Josephson, and U. Mahmood. 2006.

Trehin, R., J. L. Figueiredo, M. J. Pittet, R. Weissleder, L. Josephson, and U. Mahmood. 2006. Fluorescent nanoparticle uptake for brain tumor visualization. Neoplasia 8(4):302–311.

Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×

Wang, J., S. Tian, R. A. Petros, M. E. Napier, and J. M. DeSimone. 2010. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. Journal of the American Chemical Society 132(32):11306–11313.

Zhao, Y., and H. Singh Nalwa. 2006. Nanotoxicology: Interactions of nanomaterials with biological systems. Los Angeles, CA: American Scientific Publishers.

Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×

This page intentionally left blank.

Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×
Page 69
Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×
Page 70
Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×
Page 71
Suggested Citation:"References." Institute of Medicine. 2011. Nanotechnology and Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13037.
×
Page 72
Next: Acronyms »
Nanotechnology and Oncology: Workshop Summary Get This Book
×
Buy Paperback | $31.00 Buy Ebook | $24.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market.

The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!